Clinical Trials Logo

Filter by:
NCT ID: NCT05683275 Completed - Clinical trials for Lateral Epicondylitis

Short and Long Term Effects of IASTM and ESWT Therapy in Individuals With Lateral Epicondylitis

Start date: December 28, 2022
Phase: N/A
Study type: Interventional

Pain, decreased grip strength, and loss of function are observed in individuals with lateral epicondylitis. The aim of this study is to investigate the effects of ESWT and IASTM applications on pain, grip strength and function in individuals with lateral epicondylitis.

NCT ID: NCT05683262 Recruiting - Coccyx Disorder Clinical Trials

The Effect of USG-Guided Coccygeal Nerve Block on Sacrococcygeal and/or Intercoccygeal Joint Injection for Coccydynia

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

Coccydynia refers to a significant pain, that does not radiate, in and around the coccyx region. This symptom is typically worsen while sitting, especially on hard surfaces, standing up from sitting position and standing for long time. The steroid and anesthetic injection to the sacrococcygeal, intercoccygeal joints and impar ganglions are the most commonly cited second line management option in the literatures for refractor cases. The coccygeal nerve blockade or radiofrequency ablation is also used for coccydynia especially for traumatic cases. The aim of the study is; to evaluate the efficacy of ultrasound-guided sacrococcygeal and/or intercoccygeal joint injection in coccydynia and to investigate whether coccygeal nerve blockade has an additional contribution to this treatment.

NCT ID: NCT05683210 Completed - Heart Rate Clinical Trials

Comparison of The Effects of Initial Oral Feeding by Cup and Bottle-Feeding of Preterm Infants

Start date: January 13, 2021
Phase: N/A
Study type: Interventional

The research was planned in a randomized controlled experimental design to determine the effects of the cup and bottle used during the first oral feeding on physiological characteristics and feeding performance in preterm infants. The research was carried out between January 2021 and February 2022 at the Neonatal Intensive Care Unit of Göztepe Süleyman Yalçın City Hospital. Research data were obtained from preterm infants who were born before 34 weeks of gestation, appropriate to selection of study group criterias and hospitalized in the neonatal intensive care unit. A total of 80 babies in the sample group were randomly assigned to the experimental (bottle) and control (cup) groups. Oxygen saturation, heart rate, feeding performance and test weight before, during and after feeding of preterms in both groups were compared. There was no statistically significantly difference between the experimental and control groups in terms of oxygen saturation and heart rate.

NCT ID: NCT05682963 Completed - Multiple Sclerosis Clinical Trials

Efficacy of Square- Stepping Exercises in Individuals With Multiple Sclerosis

Start date: November 29, 2022
Phase: N/A
Study type: Interventional

Square stepping exercises can promote correct foot placement, fast and coordinated step patterns, and sensory-motor interaction. The aim of this study is to examine the effect of square stepping exercises on mobility, balance and knee joint position sense in individuals with multiple sclerosis.

NCT ID: NCT05682651 Completed - COVID-19 Clinical Trials

Relationship Between Post-Intubation Tracheal Stenosis and Covid-19

Start date: December 28, 2022
Phase:
Study type: Observational

Tracheal stenosis (TS) is a serious complication that occurs in approximately 6-22% of patients due to prolonged endotracheal intubation. Cuff hyperinflation of the endotracheal tube, use of large tubes, advanced age, female gender, smoking, obesity, and diabetes are risk factors for TS. The most common and serious complication in COVID-19 patients is acute respiratory distress syndrome (ARDS), which requires oxygen and ventilation treatments. In the literature, it is reported that 9.8-15.2% of patients need invasive mechanical ventilation (IMV). The concern of aerosol formation and prone position applications that emerged with the coronavirus pandemic caused delays in tracheostomy decisions and the use of uncontrolled high cuff pressures, paving the way for TS. The capillary perfusion pressure of the tracheal mucosa ranges from 20 to 30 mmHg. A cuff pressure of the endotracheal tube above 30 mmHg causes mucosal ischemia. Cartilage inflammation due to ischemic injury may be partial or full thickness. Depending on the degree of inflammation in the affected tracheal segments, stenosis and even perforation may develop. It is aimed to determine the etiological causes, to determine how much of the total TS cases covid-related TS constitutes, to examine the treatments and patient results in covid/non-covid TS. This study will contribute to the measures that can be taken during and after the care process in the intensive care unit.

NCT ID: NCT05682534 Completed - CrossFit Clinical Trials

Examination of Musculoskeletal System Problems and Affecting Factors in CrossFit Sports

Start date: March 21, 2023
Phase:
Study type: Observational

This study aims to determine the relationship between musculoskeletal system problems and physical risk factors in CrossFit athletes. Athletes who do CrossFit training in the Turkish Republic of Northern Cyprus and meet the inclusion criteria will be included in the study. Individuals will first be asked about their personal information, when they started CrossFit, and their previous injury information. Then, the muscle strength, functionality, stability, balance of the lower extremity muscles and body posture in different positions will be evaluated with the determined tests. Evaluations are in a single day and in total 45 minutes. is planned in.

NCT ID: NCT05682521 Completed - Clinical trials for Scoliosis Idiopathic Adolescent

Scoliosis and Postural Deformity Evaluation in Famagusta Region Secondary Schools

Start date: December 1, 2022
Phase:
Study type: Observational

The aim of the study is to evaluate scoliosis and postural deformities in secondary school students in Famagusta region. Secondary school students who meet the inclusion criteria will be included in the study, which will be conducted in the form of screening in public and private schools in the Famagusta region of the Turkish Republic of Northern Cyprus. Sociodemographic information of the individuals will be obtained first. Then, Adam's forward bending test, trunk rotation angle with scoliometer, foot posture index and New York posture index will be evaluated. Evaluations will be made within a single day.

NCT ID: NCT05682508 Enrolling by invitation - Clinical trials for End Stage Renal Disease

Effect of Educution in Control Nutrition and Fluid Control of Hemodialysis Patient

RCT
Start date: June 30, 2022
Phase: N/A
Study type: Interventional

Hemodialysis patients are required to adhere to diet and fluid restriction. The literature shows that hemodialysis patients have low adherence to diet and fluid restriction. Failure to adhere to fluid control increases weight gain between two dialysis sessions. Increased weight gain between two dialysis sessions can lead to signs and symptoms, such as heart failure, hypertension, edema and dyspnea. Ultrafiltration is increased during dialysis to remove excess fluid from the body between two dialysis sessions. As a result, this leads to large changes in the patient's weight during dialysis sessions, leading to hemodialysis complications such as hypotension and muscle cramps. Diet is important to prevent uremic complication for hemodialysis patient. Diet restriction purposes to minimize uremic symptoms and fluid- electrolyte imbalance. As increase failure to adhere diet, serum phosphorus serum potassium rise and weight gain between two dialysis sessions increases. As a result, problems with the cardiac system, respiratory system and bones are experienced. Diet and fluid restriction helps to prevent complications, to increase the quality of life and to reduce mortality. Therefore, diet and fluid control vitally important for hemodialysis patients. Nurses have an important place in providing diet and fluid management. Desired success can be achieved in fluid and diet control by giving planned trainings to patients by nurses. In patient education, the Health Belief Model is used as an effective guide, which explains the reason for the person's attitudes and behaviors. This model is based on explain why did the patient not adhere with the treatment and what motivates the patient. The model is based on the premise that they will change their behavior when people understand the severity of the illness. The Health Belief Model can used education on diet and fluid contol of hemodialysis patients. In this study, Health Belief Model components will be used as a guide in the preparation of the educational content to be given to hemodialysis patients. With this study planned to be done; it was aimed to determine the effect of Health Belief Model-based education on diet and fluid control of hemodialysis patients. The study was planned as a randomized controlled trial.

NCT ID: NCT05682378 Recruiting - Clinical trials for Heterozygous or Homozygous Familial Hypercholesterolemia

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies

V-PEDS-OLE
Start date: February 10, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this open-label, single arm, multicenter extension study is to evaluate the long-term safety and tolerability of inclisiran in participants with HeFH or HoFH who have completed the ORION-16 or ORION-13 studies.

NCT ID: NCT05682326 Recruiting - Anaemia Clinical Trials

Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P)

ASCEND-P
Start date: September 6, 2023
Phase: Phase 3
Study type: Interventional

This is an international, multicenter trial, evaluating pharmacokinetics (PK) (4 weeks), safety (52 weeks), and hemoglobin (Hgb) response (52 weeks) to daprodustat in children and adolescent participants with anemia associated with chronic kidney disease (CKD) incorporating 2 independent sub-trials (Non dialysis [ND] and Dialysis [D]). This study will enroll participants with anemia associated with CKD, in 2 distinct sub-populations differing only by their CKD stage and dialysis requirement (ND: CKD stage 3 to 5 not yet receiving dialysis and D: CKD stage 5d undergoing peritoneal dialysis [PD] or hemodialysis [HD]). The maximum duration of the study will be approximately 60 weeks, including Screening period (up to 4 weeks), treatment period (52 weeks), and follow-up period (4 weeks). Outcome measures are identical for the ND and D sub-trials, but will be separately assessed in each sub- trials, overall and within each age subgroups (12 to less than [<] 18 years, 6 to <12 years, 2 to <6 years, and 3 months to <2 years). Except for PK and dose change, which is within each age group only.